We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current OCC market cap is 270.03M. The company's latest EPS is AUD -0.0343 and P/E is -37.61.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 803k | 1.06M | 1.54M | 4.3M | 5.73M |
| Operating Income | -9.17M | -11.63M | -11.52M | -10.28M | -11.26M |
| Net Income | -6.15M | -9.04M | -9.11M | -6.25M | -7.18M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 23.17M | 19.33M | 37.9M | 29.61M | 26.62M |
| Total Liabilities | 2.27M | 2.46M | 27.99M | 23.46M | 22.08M |
| Total Equity | 20.9M | 16.87M | 9.91M | 6.15M | 4.53M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -5.26M | -4.63M | -6.26M | 14.59M | -6.51M |
| Investing | -55k | -189k | -535k | -631k | -942k |
| Financing | 14.52M | 709k | 1.49M | -165k | 3.24M |
| Market Cap | 270.03M |
| Price to Earnings Ratio | -37.61 |
| Price to Sales Ratio | 47.08 |
| Price to Cash Ratio | 13.1 |
| Price to Book Ratio | 59.57 |
| Dividend Yield | - |
| Shares Outstanding | 209.33M |
| Average Volume (1 week) | 1.82M |
| Average Volume (1 Month) | 1.95M |
| 52 Week Change | 244.00% |
| 52 Week High | 1.79 |
| 52 Week Low | 0.35 |
| Spread (Intraday) | 0.03 (2.29%) |
| Company Name | Orthocell Limited |
| Address |
building 191 perth, western australia 6150 |
| Website | https://www.orthocell.com.au |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
